Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 108, pseudogene (RN7SL108P)

Target
RN7SL108P
Molecular classification
Other, Pseudogene
01

Overview

RN7SL108P is a pseudogene member of the human RN7SL family, resembling the functional 7SL RNA encoding genes. The canonical 7SL RNA forms the structural RNA of the signal recognition particle (SRP), which is essential for the co-translational targeting of secretory proteins. However, RN7SL108P is nonfunctional and does not produce active RNA or protein, nor is it implicated in any known biological processes, pathways, or diseases. Pseudogenes like RN7SL108P may be transcribed at low levels but typically lack functional significance and are not considered true targets for therapeutic intervention or disease research. The functional RN7SL locus ("RNA, 7SL, cytoplasmic 1", abbreviated RN7SL1) does play key biological roles in protein targeting via the SRP and has been linked to translation arrest, immune responses, and tumor biology. Pseudogenes such as RN7SL108P are distinguishable by their lack of function, identifying characteristics such as premature stop codons or loss of necessary structural elements, and occasionally can complicate genome annotation efforts. If you are seeking a molecular target involved in cellular signaling, protein transport, or disease mechanisms, RN7SL108P is not appropriate; instead, refer to the functional "RNA, 7SL, cytoplasmic 1 (RN7SL1)" gene.

Other names
RN7SL108PRNA, 7SL, cytoplasmic 108, pseudogene
02

Mechanism of action

None. No drugs target or act upon RN7SL108P

03

Biological functions

None known for RN7SL108P. It does not encode a functional RNA or protein and lacks documented biological activity
04

Disease associations

None known. Pseudogenes generally do not play direct roles in disease, although rare exceptions exist in the literature in other gene families
05

Safety considerations

None. There are no notable safety or therapeutic challenges specifically associated with RN7SL108P
06

Interacting drugs

None. RN7SL108P does not interact with any known drugs, nor does it serve as a druggable target
07

Biomarkers

None. Pseudogenes are not used as biomarkers for patient selection or efficacy monitoring (though functional pseudogene transcripts from other loci sometimes serve as biomarkers in rare cases, not for RN7SL108P)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 108, pseudogene (RN7SL108P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 108, pseudogene (RN7SL108P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call